# Open Label Safety/Efficacy Study of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Gout Patients

> **NCT01416402** · PHASE2 · COMPLETED · sponsor: **Gilead Sciences** · enrollment: 27 (actual)

## Conditions studied

- Hyperuricemia
- Gout

## Interventions

- **DRUG:** Arhalofenate
- **DRUG:** Febuxostat
- **DRUG:** Colchicine

## Key facts

- **NCT ID:** NCT01416402
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2015-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01416402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01416402, "Open Label Safety/Efficacy Study of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Gout Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01416402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*